Cargando…
Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping
Structure-guided drug discovery emerged in the 1970s and 1980s, stimulated by the three-dimensional structures of protein targets that became available, mainly through X-ray crystal structure analysis, assisted by the development of synchrotron radiation sources. Structures of known drugs or inhibit...
Autores principales: | Thomas, Sherine E., Collins, Patrick, James, Rory Hennell, Mendes, Vitor, Charoensutthivarakul, Sitthivut, Radoux, Chris, Abell, Chris, Coyne, Anthony G., Floto, R. Andres, von Delft, Frank, Blundell, Tom L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501894/ https://www.ncbi.nlm.nih.gov/pubmed/31030650 http://dx.doi.org/10.1098/rsta.2018.0422 |
Ejemplares similares
-
Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design
por: Thomas, Sherine E., et al.
Publicado: (2022) -
Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification
por: Thomas, Sherine E, et al.
Publicado: (2020) -
Development of
Inhibitors against Mycobacterium
abscessus tRNA (m(1)G37) Methyltransferase
(TrmD) Using Fragment-Based Approaches
por: Whitehouse, Andrew J., et al.
Publicado: (2019) -
Fragment Hotspot Mapping to Identify Selectivity-Determining
Regions between Related Proteins
por: Smilova, Mihaela D., et al.
Publicado: (2022) -
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
por: Arif, Sheikh Mohammed, et al.
Publicado: (2022)